The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast

Irina L. Derkatch, Michael E. Bradley, Ping Zhou, Susan W. Liebman

Research output: Contribution to journal › Article

47 Citations (Scopus)

Abstract

We have previously described different variants of the yeast prion [PSI+] that can be obtained and maintained in the same genetic background. These [PSI+] variants, which differ in the efficiency of nonsense suppression, mitotic stability and the efficiency of curing by GuHCl, may correspond to different [PSI+] prion conformations of Sup35p or to different types of prion aggregates. Here we investigate the effects of overexpressing a mutant allele of SUP35 and find different effects on weak and strong [PSI+] variants: the suppressor phenotype of weak [PSI+] factors is increased, whereas the suppressor effect of strong [PSI+] factors is reduced. The SUP35 mutation used was originally described as a 'Psi no more' mutation (PNM2) because it caused loss of [PSI+]. However, none of the [PSI+] variants in the strains used in our study were cured by PNM2. Indeed, when overexpressed, PNM2 induced the de novo appearance of both weak and strong [PSI+] variants with approximately the same efficiency as the overexpressed wild-type SUP35 allele. Our data suggest that the change in the region of oligopeptide repeats in the Sup35p N-terminus due to the PNM2 mutation modifies, but does not impair, the function of the prion domain of Sup35p.

Original languageEnglish (US)
Pages (from-to)59-67
Number of pages9
JournalCurrent Genetics
Volume35
Issue number2
DOIs
StatePublished - Apr 2 1999
Externally publishedYes

Fingerprint

Prions
Yeasts
Mutation
Alleles
Oligopeptides
Phenotype
Protein Domains
Prion Proteins

Keywords

  • [PSI]
  • Nonsense-suppression
  • PNM mutant
  • Prions
  • SUP35
  • Translation termination

ASJC Scopus subject areas

  • Genetics

Cite this

The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. / Derkatch, Irina L.; Bradley, Michael E.; Zhou, Ping; Liebman, Susan W.

In: Current Genetics, Vol. 35, No. 2, 02.04.1999, p. 59-67.

Research output: Contribution to journal › Article

Derkatch, IL, Bradley, ME, Zhou, P & Liebman, SW 1999, 'The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast', Current Genetics, vol. 35, no. 2, pp. 59-67. https://doi.org/10.1007/s002940050433
Derkatch IL, Bradley ME, Zhou P, Liebman SW. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. Current Genetics. 1999 Apr 2;35(2):59-67. https://doi.org/10.1007/s002940050433
Derkatch, Irina L. ; Bradley, Michael E. ; Zhou, Ping ; Liebman, Susan W. / The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. In: Current Genetics. 1999 ; Vol. 35, No. 2. pp. 59-67.
@article{ba35c176971548c79af2dd709d3530d3,
title = "The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast",
abstract = "We have previously described different variants of the yeast prion [PSI+] that can be obtained and maintained in the same genetic background. These [PSI+] variants, which differ in the efficiency of nonsense suppression, mitotic stability and the efficiency of curing by GuHCl, may correspond to different [PSI+] prion conformations of Sup35p or to different types of prion aggregates. Here we investigate the effects of overexpressing a mutant allele of SUP35 and find different effects on weak and strong [PSI+] variants: the suppressor phenotype of weak [PSI+] factors is increased, whereas the suppressor effect of strong [PSI+] factors is reduced. The SUP35 mutation used was originally described as a 'Psi no more' mutation (PNM2) because it caused loss of [PSI+]. However, none of the [PSI+] variants in the strains used in our study were cured by PNM2. Indeed, when overexpressed, PNM2 induced the de novo appearance of both weak and strong [PSI+] variants with approximately the same efficiency as the overexpressed wild-type SUP35 allele. Our data suggest that the change in the region of oligopeptide repeats in the Sup35p N-terminus due to the PNM2 mutation modifies, but does not impair, the function of the prion domain of Sup35p.",
keywords = "[PSI], Nonsense-suppression, PNM mutant, Prions, SUP35, Translation termination",
author = "Derkatch, {Irina L.} and Bradley, {Michael E.} and Ping Zhou and Liebman, {Susan W.}",
year = "1999",
month = "4",
day = "2",
doi = "10.1007/s002940050433",
language = "English (US)",
volume = "35",
pages = "59--67",
journal = "Current Genetics",
issn = "0172-8083",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast

AU - Derkatch, Irina L.

AU - Bradley, Michael E.

AU - Zhou, Ping

AU - Liebman, Susan W.

PY - 1999/4/2

Y1 - 1999/4/2

N2 - We have previously described different variants of the yeast prion [PSI+] that can be obtained and maintained in the same genetic background. These [PSI+] variants, which differ in the efficiency of nonsense suppression, mitotic stability and the efficiency of curing by GuHCl, may correspond to different [PSI+] prion conformations of Sup35p or to different types of prion aggregates. Here we investigate the effects of overexpressing a mutant allele of SUP35 and find different effects on weak and strong [PSI+] variants: the suppressor phenotype of weak [PSI+] factors is increased, whereas the suppressor effect of strong [PSI+] factors is reduced. The SUP35 mutation used was originally described as a 'Psi no more' mutation (PNM2) because it caused loss of [PSI+]. However, none of the [PSI+] variants in the strains used in our study were cured by PNM2. Indeed, when overexpressed, PNM2 induced the de novo appearance of both weak and strong [PSI+] variants with approximately the same efficiency as the overexpressed wild-type SUP35 allele. Our data suggest that the change in the region of oligopeptide repeats in the Sup35p N-terminus due to the PNM2 mutation modifies, but does not impair, the function of the prion domain of Sup35p.

AB - We have previously described different variants of the yeast prion [PSI+] that can be obtained and maintained in the same genetic background. These [PSI+] variants, which differ in the efficiency of nonsense suppression, mitotic stability and the efficiency of curing by GuHCl, may correspond to different [PSI+] prion conformations of Sup35p or to different types of prion aggregates. Here we investigate the effects of overexpressing a mutant allele of SUP35 and find different effects on weak and strong [PSI+] variants: the suppressor phenotype of weak [PSI+] factors is increased, whereas the suppressor effect of strong [PSI+] factors is reduced. The SUP35 mutation used was originally described as a 'Psi no more' mutation (PNM2) because it caused loss of [PSI+]. However, none of the [PSI+] variants in the strains used in our study were cured by PNM2. Indeed, when overexpressed, PNM2 induced the de novo appearance of both weak and strong [PSI+] variants with approximately the same efficiency as the overexpressed wild-type SUP35 allele. Our data suggest that the change in the region of oligopeptide repeats in the Sup35p N-terminus due to the PNM2 mutation modifies, but does not impair, the function of the prion domain of Sup35p.

KW - [PSI]

KW - Nonsense-suppression

KW - PNM mutant

KW - Prions

KW - SUP35

KW - Translation termination

UR - http://www.scopus.com/inward/record.url?scp=0033058714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033058714&partnerID=8YFLogxK

U2 - 10.1007/s002940050433

DO - 10.1007/s002940050433

M3 - Article

C2 - 10079323

AN - SCOPUS:0033058714

VL - 35

SP - 59

EP - 67

JO - Current Genetics

JF - Current Genetics

SN - 0172-8083

IS - 2

ER -

Access to Document